Last reviewed · How we verify

NCT06372327: MOVD

Move Often eVery Day 2.0

ENROLLING BY INVITATION NA Last updated 3 August 2025
What this trial tests

NA trial testing Daily Exercise Snacks in Exercise in 40 participants. Enrolling by invitation.

Timeline
31 July 2024
Primary endpoint
1 July 2026
1 July 2026

Quick facts

Lead sponsorStanford University
PhaseNA
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationrandomized
Designfactorial
Maskingnone
Primary purposeprevention
Enrollment40
Start date31 July 2024
Primary completion1 July 2026
Estimated completion1 July 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Stanford University

Who can join

30 and older, female only, with Exercise. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to assess a novel, widely-accessible intervention to both promote active breaks from work and improve cognitive and psychological performances at work in motivationally-accessible bouts. This will be done by interrupting prolonged sitting with 1-4 short (1-4 minutes), moderate-to-vigorous physical activity (MVPA) bouts with no equipment, and simple video-based instructions. The short bouts will be referred to as "exercise snacks." In this proposed exercise snacks intervention, investigators explicitly target a population with sedentary jobs due to the generalizability.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Exercise

Currently open trials in the same condition.

Other Stanford University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06372327.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing